Can You Take Oxycodone with Zolpidem?
A plain-English look at the major interaction between Oxycodone (Oxycodone BNM) and Zolpidem (STILNOX Zolpidem tartrate 10mg tablet blister pack) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Taking Oxycodone (Oxycodone BNM) with Zolpidem (STILNOX Zolpidem tartrate 10mg tablet blister pack) is a major drug interaction that should be avoided. Respiratory depression, excessive sedation, overdose. Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Major
- Risk: Respiratory depression, excessive sedation, overdose.
- Mechanism: Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.
- Oxycodone: S8 in Australia, high risk
- Zolpidem: S4 in Australia, moderate risk
- Claims action: Flag for immediate prescriber review. Document intervention in claim file.
Oxycodone vs Zolpidem at a Glance
| Property | Oxycodone | Zolpidem |
|---|---|---|
| Brand names | Oxycodone BNM, OxyNorm, Oxycodone Sandoz | STILNOX Zolpidem tartrate 10mg tablet blister pack, ZOLPIDEM SANDOZ PHARMA zolpidem tartrate 10 mg tablet blister pack, ZOLPIDEM SANDOZ PHARMA zolpidem tartrate 10 mg tablet bottle |
| Drug class | opioid | z drug |
| Risk level | high | moderate |
| TGA Schedule (AU) | S8 | S4 |
Why Is This Combination Dangerous?
Additive CNS and respiratory depression. Z-drugs enhance GABAergic activity while opioids suppress brainstem respiratory centres.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.
United Kingdom NICE / MHRA / FPM
UK clinical guidelines recommend caution with this combination. For personal injury claims, the prescribing rationale should be documented and reviewed against NICE and FPM guidance.
United States FDA / CDC / State WC
The CDC and FDA recommend monitoring concurrent CNS depressant use. State workers compensation formularies may restrict or require prior authorization for this combination.
What Claims Professionals Should Do
- Flag immediately as a high-risk prescribing pattern in the claim file
- Request urgent prescriber review with documented clinical justification for the combination
- Consider an independent medical examination if the prescriber cannot provide adequate justification
- Assess work capacity impact as the combination significantly increases sedation and impairment risk
- Document all interventions for audit trail and compliance purposes
- Check Reasonable and Necessary status for both medications against the compensable injury
Check this medication against your full medication list
Check all interactions for Oxycodone and Zolpidem across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.